Varnaitė R

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.

Sandberg JT, Varnaitė R, Christ W, ..., Gredmark-Russ S, Karolinska COVID‐19 Study Group

Clin Transl Immunol 10 (7) e1306 [2021-07-05; online 2021-07-05]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Host cell systems biology and targets Type: Journal article

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.

Varnaitė R, García M, Glans H, ..., Klingström J, Gredmark-Russ S

J Immunol 205 (9) 2437-2446 [2020-11-01; online 2020-09-02]

Category: Biochemistry Category: Health Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Host cell systems biology and targets Type: Journal article